MSL, MA, MM, MAM, MD ?. this is your day
First Belgian Medical Affairs day organised by BeAPP
Speakers already confirmed
Marc Van Uytven, CEO Ziekenhuis Aalst, The reform of hospital funding and other reforms impacting the running of a hospital in Belgium.
Prof. Cedric Hermans, Chef Service d?h?matologie, Cliniques Universitaires Saint-Luc
Prof Koen Demyttenaere, ?Professor Psychiatry at KU Leuven ? ?University Psychiatric Center KU Leuven
Bruno Van Eesbeeck, Associate, Alfa Management Consulting
Mich?le Sangeleer, Medical Director Eli Lilly, Basic training concerning EMA
Matthias Schifflers, Medical Director MSD, The strategic role of the MSL, MA, MAM, MM, ? and the medical departement.
Rudy De Cock, Director Global Health & Value, Pfizer Belgium
Programme
09:00 Intro
Erik Present, President BeAPP and Director Medical Affairs Janssen Benelux
09:05 Upcoming reform in hospital financing: the view of the authority
Bruno Van Eesbeeck, Associate, Alfa Management Consulting
09:40 Upcoming reform in hospital financing: the view of the hospitals
Marc Van Uytven, CEO OLV Aalst-Asse-Ninove
10:15 Break
10:30 EMA regulation and your daily job
Mich?le Sangeleer, Medical Director Eli Lilly & Co
11:30 Early temporary authorisation/reimbursement: status update
Rudy De Cock, Director Global Health & Value, Pfizer Belgium
12:00 Lunch
13:00 The strategic role of the MSL, MA, MAM, MM, ? and the medical departement
Mathias Schifflers, Medical Director, MSD Belgium
13:30 The relation between the Health Care Professional and Pharma ? a stakeholdersdebate
Prof. Cedric Hermans, Chef Service d?h?matologie, Cliniques Universitaires Saint-Luc
Prof Koen Demyttenaere, ?Professor Psychiatry at KU Leuven ? ?University Psychiatric Center KU Leuven
Mathias Schifflers, Medical Director MSD Belgium
Stefaan Vancayzeele, CSO Novartis Belgium
Kristel De Gauquier, Medical Director Pharma.be (moderator)
15:00 Closing
Erik Present, President BeAPP and Director Medical Affairs Janssen Benelux
15:15 Closing drink
Stefaan Vancayzeele, Chief Scientific Officer Novartis Belgium
Erik Present, Director Medical Affairs Janssen Benelux